Transactions

Aptinyx Inc. is a clinical stage biopharmaceutical company. The Company focused on discovering and developing therapies for disorders of the brain and nervous system.

Generation Bio is a biotechnology company working to extend the benefits of gene therapy to more families, living with a broader range of diseases around the world.

Mirati Therapeutics, Inc. is a clinical stage biopharmaceutical company. The Company is focused on developing a pipeline of targeted oncology products.

Contango Oil & Gas is a Houston, TX based, independent upstream oil and gas company focused on exploring, developing, exploiting, producing, and acquiring crude oil and natural gas properties.

KemPharm is a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs to treat serious medical conditions through its proprietary LATTM (Ligand Activated Therapy) technology.

Akerna is the parent company resulting from the merger between MJ Freeway and MTech Acquisition Corp., the first US listed Special Purpose Acquisition Company (SPAC) focused on acquiring a cannabis technology company.

Quarton, A Cowen Company advised the investment company Bregal Unternehmerkapital GmbH on the acquisition financing for the purchase of EA Elektro Automatik GmbH, a producer and distributer of power electronics.

CallMiner is the leading SaaS customer engagement and speech analytics platform that differentiates itself via its ability to analyze speech in real time.

Cowen is pleased to announce the sale of Jagged Peak, Inc. a subsidiary of Singapore Post Limited, an affiliate of Singapore’s public post office. Jagged Peak was sold to ID Logistics US, Inc.

Cowen is pleased to announce the sale of TradeGlobal, LLC, a subsidiary of Singapore Post Limited, an affiliate of Singapore’s public post office. TradeGlobal was sold to Visible Supply Chain Management, LLC.

Constellation Pharmaceuticals is a clinical stage biopharmaceutical company developing novel therapeutics that selectively modulate gene expression to address serious unmet medical needs in patients with cancer.

Rocket Pharmaceuticals, Inc. is a clinical stage biotechnology company focused on developing gene therapy treatment options for rare, devastating diseases.